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Personalized medicine is recently emerging trend, therefore pharmaceutical industry faces a 
new challenge on providing solid dosage forms, which as still the most favourable medicines, 
with tailorable properties. A novel approach may be the utilization of drug-polymer 
interactions in the development of solid delivery matrices. 
A line of chemically similar drugs with increasing acid strength were mixed various matrix 
forming agents and directly compressed with an instrumented IMA Kilian SP300 tablet press. 
Kawakita and Walker analysis were made to evaluate the composition’s compressibility. 
Compressibility studies showed an increment in the energy value needed for deformation, 
which may be due to particles attracted to each other causing chemical interactions. 
The presence of solid-state drug-polymer interactions based on the formation of H-bonds 
were confirmed by FT-IR spectroscopy.  
A custom-made device was applied to perform dissolution tests to obtain information on the 
effect of interactions on the drug liberation kinetics. The results of dissolution tests proved 
that strength of interactions have increased due to formation of polyelectrolyte complexes 
which exerted considerable influence on both the quantity of liberated drug and the speed of 
drug liberation.  
According to the findings it may be concluded that inclusion of the physico-chemical 
properties of raw materials and careful evaluation of their potential interactions during the 
development phase of the drug delivery systems may open new ways to provide medicines 
with tailored properties. 
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